Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Precursor inactive

Alkynes with EWGs are poor substrates for the coupling with halides. Therefore, instead of the inactive propynoate, triethyl orthopropynoate (350) is used for the coupling with aryl halides to prepare the arylpropynoate 351. The coupling product 353 of 3,3-dicthoxy-l-propyne (352) with an aryl halide is the precursor of an alkynal[260]. The coupling of ethoxy) tributylstan-nyl)acetylene (354) with aryl halides is a good synthetic method for the aryl-acetate 355[261]. [Pg.177]

The polypeptide chain of chymotrypsinogen, the inactive precursor of chymotrypsin, comprises 245 amino acids. During activation of chymotrypsinogen residues 14-15 and 147-148 are excised. The remaining three polypeptide chains are held together by disulfide bridges to form the active chymotrypsin molecule. [Pg.210]

Figure 11.7 Schematic diagram of the structure of chymotrypsin, which is folded into two antiparallel p domains. The six p strands of each domain are red, the side chains of the catalytic triad are dark blue, and the disulfide bridges that join the three polypeptide chains are marked in violet. Chain A (green, residues 1-13) is linked to chain B (blue, residues 16-146) by a disulfide bridge between Cys 1 and Cys 122. Chain B is in turn linked to chain C (yellow, residues 149-245) by a disulfide bridge between Cys 136 and Cys 201. Dotted lines indicate residues 14-15 and 147-148 in the inactive precursor, chmotrypsinogen. These residues are excised during the conversion of chymotrypsinogen to the active enzyme chymotrypsin. Figure 11.7 Schematic diagram of the structure of chymotrypsin, which is folded into two antiparallel p domains. The six p strands of each domain are red, the side chains of the catalytic triad are dark blue, and the disulfide bridges that join the three polypeptide chains are marked in violet. Chain A (green, residues 1-13) is linked to chain B (blue, residues 16-146) by a disulfide bridge between Cys 1 and Cys 122. Chain B is in turn linked to chain C (yellow, residues 149-245) by a disulfide bridge between Cys 136 and Cys 201. Dotted lines indicate residues 14-15 and 147-148 in the inactive precursor, chmotrypsinogen. These residues are excised during the conversion of chymotrypsinogen to the active enzyme chymotrypsin.
Each precursor protein molecule is cleaved only once to generate one molecule of the coat protein, and catalytic activity is restricted to the precursor protein. Why is the coat protein itself catalytically inactive The structure of the coat protein shows that its C-terminus is bound in the active site cleft and thereby prevents other proteins entering the cleft and being cleaved. Tbis arrangement allows the precursor protein to fulfill its function to generate the coat protein and prevents the coat protein from destroying other proteins in the infected cell, including other coat proteins. [Pg.341]

INSULIN. Some protein hormones are synthesized in the form of inactive precursor molecules, from which the active hormone is derived by proteolysis. For instance, insulin, an important metabolic regulator, is generated by proteolytic excision of a specific peptide from proinsulin (Figure 15.3). [Pg.464]

Active a-chymotrypsin is produced from chymotrypsinogen, an inactive precursor, as shown in the color figure on page 530. [Pg.531]

Paraffins are relatively inactive compared to olefins, diolefins, and aromatics. Few chemicals could be obtained from the direct reaction of paraffins with other reagents. However, these compounds are the precursors for olefins through cracking processes. The C -Cg paraffins and cycloparaffms are especially important for the production of aromatics through reforming. This section reviews some of the physical and chemical properties of C1-C4 paraffins. Long-chain paraffins normally present as mixtures with other hydrocarbon types in different petroleum fractions are discussed later in this chapter. [Pg.29]

A different approach to making chiral drugs is asymmetric synthesis. An optically inactive precursor is converted to the drug by a reaction that uses a special catalyst, usually an enzyme (Chapter 11). If all goes well, the product is a single enantiomer with the desired physiological effect In 2001, William S. Knowles, Ryogi Noyori, and K. Barry Sharpless won the Nobel Prize in chemistry for work in this area. [Pg.601]

In addition SENPs are required for maturation of SUMO precursors. SUMO proteins are translated as inactive precursors with a short C-terminal prosequence of variable length. This sequence needs to be removed to expose a double glycine motif at the C-terminus of SUMO that is required for conjugation. [Pg.1164]

The synthesis and metabolism of trace amines and monoamine neurotransmitters largely overlap [1]. The trace amines PEA, TYR and TRP are synthesized in neurons by decarboxylation of precursor amino acids through the enzyme aromatic amino acid decarboxylase (AADC). OCT is derived from TYR. by involvement of the enzyme dopamine (3-hydroxylase (Fig. 1 DBH). The catabolism of trace amines occurs in both glia and neurons and is predominantly mediated by monoamine oxidases (MAO-A and -B). While TYR., TRP and OCT show approximately equal affinities toward MAO-A and MAO-B, PEA serves as preferred substrate for MAO-B. The metabolites phenylacetic acid (PEA), hydroxyphenylacetic acid (TYR.), hydroxymandelic acid (OCT), and indole-3-acetic (TRP) are believed to be pharmacologically inactive. [Pg.1218]

Trace Amines. Figure 1 The main routes of trace amine metabolism. The trace amines (3-phenylethylamine (PEA), p-tyramine (TYR), octopamine (OCT) and tryptamine (TRP), highlighted by white shading, are each generated from their respective precursor amino acids by decarboxylation. They are rapidly metabolized by monoamine oxidase (MAO) to the pharmacologically inactive carboxylic acids. To a limited extent trace amines are also A/-methylated to the corresponding secondary amines which are believed to be pharmacologically active. Abbreviations AADC, aromatic amino acid decarboxylase DBH, dopamine b-hydroxylase NMT, nonspecific A/-methyltransferase PNMT, phenylethanolamine A/-methyltransferase TH, tyrosine hydroxylase. [Pg.1219]

The complex 65 was synthesized by reaction of the imidazolinium salt with the precursor ruthenium complex 67 (catalytically inactive) in the presence of silver carbonate (Scheme 42). The complex being air-stable and stable on silicagel was isolated in 52% yield after chromatography. The diastereomeric and enantiomeric purity of 65 was determined by HPLC analysis and found to be above 98% (de and ee). The molecular structure was determined by X-ray analysis and showed the unusual twist geometry of this complex. [Pg.218]

Some chiral mono-, acyl- and di-thioureas have been used as ligand for the Rh-catalysed asymmetric hydroformylation of styrene. Although thiourea ligands form inactive systems with [Rh(COD)Cl]2 as the catalyst precursor, in standard conditions (40 °C, 40 bar CO -l- H2 1/1), the cationic Rh complex [Rh(COD)2]Bp4 combined with monothioureas as the ligand showed moderate to good activity (Scheme 29) [114]. [Pg.251]

Chiral lactones were also obtained by cyclocarbonylation of chiral acetylenic alcohols with Pd and thiourea (H2NCSNH2) (Scheme 32). No loss in chirality was observed, but large amounts of Pd and thiourea were used (10 mol %) since the catalyst deactivates by forming metal particles. The catalytic precursor (Pdl2 > PdCl2) and the ratio of thiourea to Pd were very important, thiourea being necessary for this reaction. The active species was supposed to be [Pd(thiourea)3l]I, which forms in situ from [Pd(thiourea)4]l2 and [Pd(thiourea)2]l2. It had to be a partially dissociated species since [Pd(thiourea)4](Bp4)2 was inactive [121]. [Pg.252]

The proteases are secreted as inactive zymogens the active site of the enzyme is masked by a small region of its peptide chain, which is removed by hydrolysis of a specific peptide bond. Pepsinogen is activated to pepsin by gastric acid and by activated pepsin (autocatalysis). In the small intestine, trypsinogen, the precursor of trypsin, is activated by enteropeptidase, which is secreted by the duodenal epithelial cells trypsin can then activate chymotrypsinogen to chymotrypsin, proelas-tase to elastase, procarboxypeptidase to carboxypepti-dase, and proaminopeptidase to aminopeptidase. [Pg.477]

Fibrin is dissolved by plasmin. Plasmin exists as an inactive precursor, plasminogen, which can be activated by tissue plasminogen activator (t-PA). Both t-PA and streptokinase are widely used to treat early thrombosis in the coronary arteries. [Pg.608]

The H locus codes for this fiicosyltransferase. The h allele of the H locus codes for an inactive fucosyltrans-ferase therefore, individuals of the hh genotype cannot generate H substance, the precursor of the A and B antigens. Thus, individuals of the hh genotype will have red blood cells of type O, even though they may possess the enzymes necessary to make the A or B substances (see below). [Pg.618]

A few methods produce reactive molecules by reactions in solid matrices. The most widely used consists of irradiating already isolated precursors with UV light (including vacuum UV light at A < 200 nm), y- or X-rays. In this case, the fragments which are formed as products of the precursor s dissociation must not recombine in the matrix site. To achieve this effect, one of the fragments should be either chemically inactive [e.g. N2, CO2 see (la)] or able to diffuse easily from the site [e.g. hydrogen atoms as in (lb)]. [Pg.4]

Prodrug. Inactive precursor of a dmg which is converted into its active form in the body by normal metabolic processes. [Pg.251]


See other pages where Precursor inactive is mentioned: [Pg.275]    [Pg.371]    [Pg.39]    [Pg.199]    [Pg.71]    [Pg.295]    [Pg.275]    [Pg.371]    [Pg.39]    [Pg.199]    [Pg.71]    [Pg.295]    [Pg.408]    [Pg.534]    [Pg.200]    [Pg.517]    [Pg.279]    [Pg.103]    [Pg.309]    [Pg.92]    [Pg.464]    [Pg.187]    [Pg.673]    [Pg.885]    [Pg.1127]    [Pg.1202]    [Pg.298]    [Pg.264]    [Pg.76]    [Pg.447]    [Pg.597]    [Pg.602]    [Pg.605]    [Pg.623]    [Pg.215]    [Pg.20]    [Pg.23]   
See also in sourсe #XX -- [ Pg.289 , Pg.292 ]




SEARCH



Chymotrypsinogen inactive precursor

Inactive

Procarboxypeptidase, inactive precursor

© 2024 chempedia.info